It was also found in leukemia cells that non-coding variants at KRAS and PER2 enhancers affect the binding of nuclear receptor family TFs PPARG and RXRA, which disturbs the expression of KRAS and PER2 and promotes the growth of leukemia cells [14]. This evidence concerns the gene PER2 and leukemia.